Phaseline

Targets › UL30

UL30: drug programs, companies and trials

1 program from 1 company in 1 trial: 1 Phase 4; Infectious disease.

Open in Phaseline: the race on UL30, likelihood bands and readouts

Programs

CompanyDrugTargetsHighest phaseConditionsNext expected readout
University of GuadalajaraValganciclovir
Human herpesvirus 1 DNA polymerase inhibitor
UL30Phase 4Cytomegalovirus Infections–

Conditions

Cytomegalovirus Infections (1)

Modalities

small molecule (1)

Companies

University of Guadalajara (1)

Related targets

–

Programs group each company's trials by drug; targets and mechanisms come from Open Targets and ChEMBL via Open Targets; expected readouts are Phaseline's estimate from the registry's primary completion date. Facts from the registries only; the approval likelihood is in the app.